Neuroprosthetic baroreflex controls haemodynamics after spinal cord injury.
Jordan W SquairMatthieu GautierLois MaheJan Elaine SorianoAndreas RowaldArnaud BichatNewton ChoMark A AndersonNicholas D JamesJerome GandarAnthony V IncognitoGiuseppe SchiavoneZoe K SarafisAchilleas LaskaratosKay BartholdiRobin DemesmaekerSalif KomiCharlotte MoermanBita VaseghiBerkeley ScottRyan RosentreterClaudia KatheJimmy RavierLaura McCrackenXiaoyang KangNicolas VachicourasFlorian FalleggerIleana O JelescuYunLong ChengQin LiRik BuschmanNicolas BuseTim DenisonSean DukelowRebecca CharbonneauIan RigbySteven K BoydPhilip J MillarEduardo Martin MoraudMarco CapogrossoFabien B WagnerQuentin BarraudErwan BezardStephanie P LacourJocelyne BlochGrégoire CourtineAaron A PhillipsPublished in: Nature (2021)
Spinal cord injury (SCI) induces haemodynamic instability that threatens survival1-3, impairs neurological recovery4,5, increases the risk of cardiovascular disease6,7, and reduces quality of life8,9. Haemodynamic instability in this context is due to the interruption of supraspinal efferent commands to sympathetic circuits located in the spinal cord10, which prevents the natural baroreflex from controlling these circuits to adjust peripheral vascular resistance. Epidural electrical stimulation (EES) of the spinal cord has been shown to compensate for interrupted supraspinal commands to motor circuits below the injury11, and restored walking after paralysis12. Here, we leveraged these concepts to develop EES protocols that restored haemodynamic stability after SCI. We established a preclinical model that enabled us to dissect the topology and dynamics of the sympathetic circuits, and to understand how EES can engage these circuits. We incorporated these spatial and temporal features into stimulation protocols to conceive a clinical-grade biomimetic haemodynamic regulator that operates in a closed loop. This 'neuroprosthetic baroreflex' controlled haemodynamics for extended periods of time in rodents, non-human primates and humans, after both acute and chronic SCI. We will now conduct clinical trials to turn the neuroprosthetic baroreflex into a commonly available therapy for people with SCI.
Keyphrases
- spinal cord injury
- spinal cord
- neuropathic pain
- cardiovascular disease
- clinical trial
- endothelial cells
- liver failure
- transcription factor
- type diabetes
- stem cells
- bone marrow
- intensive care unit
- cell therapy
- metabolic syndrome
- mesenchymal stem cells
- study protocol
- open label
- mouse model
- coronary artery disease
- lower limb
- quantum dots
- cardiovascular events